KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Capital Leases: 2017-2025

Historic Capital Leases for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Sep 2025 value amounting to $55.7 million.

  • Amneal Pharmaceuticals' Capital Leases fell 3.28% to $55.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.7 million, marking a year-over-year decrease of 3.28%. This contributed to the annual value of $56.9 million for FY2024, which is 2.86% down from last year.
  • According to the latest figures from Q3 2025, Amneal Pharmaceuticals' Capital Leases is $55.7 million, which was down 0.62% from $56.0 million recorded in Q2 2025.
  • Over the past 5 years, Amneal Pharmaceuticals' Capital Leases peaked at $61.9 million during Q1 2021, and registered a low of $55.7 million during Q3 2025.
  • In the last 3 years, Amneal Pharmaceuticals' Capital Leases had a median value of $58.0 million in 2024 and averaged $58.0 million.
  • Per our database at Business Quant, Amneal Pharmaceuticals' Capital Leases increased by 1.42% in 2021 and then dropped by 3.75% in 2025.
  • Quarterly analysis of 5 years shows Amneal Pharmaceuticals' Capital Leases stood at $60.3 million in 2021, then increased by 0.86% to $60.8 million in 2022, then declined by 3.63% to $58.6 million in 2023, then decreased by 2.86% to $56.9 million in 2024, then decreased by 3.28% to $55.7 million in 2025.
  • Its Capital Leases was $55.7 million in Q3 2025, compared to $56.0 million in Q2 2025 and $56.6 million in Q1 2025.